Lyka Labs Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

149.74

-4.07 (-2.65%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

149.74

-4.07 (-2.65%)
15:59 Dec 20

Quality

43/100
Medium Financial Strength

Valuation

19/100
Expensive Valuation

Technical

60/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	86.25	194.08	93.07	111.19	131.6
Operating Expenses +	66.57	92.93	76.23	95.48	114.05
Raw Material	34.91	53.39	38.77	45.63	54
Increase Decrease in Cost	3.06	-0.41	-1.21	-0.78	-0.91
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	14.57	18.06	18.61	26.77	30.94
Miscellaneous Expenses	59.23	74.79	51.44	50.84	30.02
Operating Profit	19.68	101.15	16.84	15.71	17.55
Other Income	1.56	2.09	3.4	1.45	1.42
Depreciation	8.32	17.35	14.15	12.8	9.26
Interest	25.94	20.13	11.87	4.89	3.54
Profit before tax and exceptio..	-13.02	65.77	-5.78	-0.52	6.17
Exceptional Items	-1.13	-6.52	-7.39	-0.41	0.02
PBT	-14.14	59.25	-13.17	-0.93	6.15
Provision for Taxation	-4.05	20.8	-0.02	1.69	3.06
Net Profit	-10.09	38.44	-13.15	-2.62	3.12
NET Profit after MI	-11.55	39	-13.21	-2.49	3.46
EPS	-4.07	13.57	-4.63	-0.79	-2.32
Operating Profit Margin (%)	22.82	52.12	18.09	14.13	13.34
Net Profit Margin (%)	-13.39	20.09	-14.19	-2.24	2.63

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	58.10	58.10	54.80	54.80	54.80
FII	0.20	0.20	0.20	0.20	0.20
MF	0.00	0.00	0.00	0.00	0.00
Public	41.10	41.00	44.10	44.40	44.60
Others	0.00	0.00	0.00	0.00	0.00
Others	0.60	0.70	0.90	0.60	0.40